We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BGS icon
2076
B&G Foods
BGS
$276M
$132K ﹤0.01%
5,563
+4,570
+460% +$114K
DIV icon
2077
Global X SuperDividend US ETF
DIV
$775M
$132K ﹤0.01%
6,795
-11,247
-62% -$230K
IEFA icon
2078
iShares Core MSCI EAFE ETF
IEFA
$195B
$132K ﹤0.01%
2,228
+1,826
+454% +$117K
PGNY icon
2079
Progyny
PGNY
$2.23B
$132K ﹤0.01%
4,545
+2,678
+143% +$95.9K
SLVM icon
2080
Sylvamo
SLVM
$1.6B
$132K ﹤0.01%
4,042
+1,988
+97% +$83.4K
SMH icon
2081
VanEck Semiconductor ETF
SMH
$70.8B
$132K ﹤0.01%
+1,292
New +$150K
BDXB
2082
DELISTED
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
$132K ﹤0.01%
2,676
-544
-17% -$27.9K
ERO icon
2083
Ero Copper
ERO
$3.73B
$131K ﹤0.01%
+15,464
New +$193K
KPTI icon
2084
Karyopharm Therapeutics
KPTI
$44.4M
$131K ﹤0.01%
1,940
+1,505
+346% +$138K
SGMO
2085
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$131K ﹤0.01%
31,752
-906
-3% -$3.92K
AKR icon
2086
Acadia Realty Trust
AKR
$2.78B
$130K ﹤0.01%
8,328
+6,938
+499% +$134K
BBU
2087
DELISTED
Brookfield Business Partners
BBU
$130K ﹤0.01%
6,166
-11,315
-65% -$276K
MUFG icon
2088
Mitsubishi UFJ Financial
MUFG
$250B
$130K ﹤0.01%
24,325
-8,097
-25% -$46.6K
QQJG
2089
DELISTED
Invesco ESG NASDAQ Next Gen 100 ETF
QQJG
$130K ﹤0.01%
7,302
+6,069
+492% +$117K
ST icon
2090
Sensata Technologies
ST
$6.73B
$130K ﹤0.01%
3,138
+859
+38% +$39.5K
CIM
2091
Chimera Investment
CIM
$982M
$129K ﹤0.01%
4,843
+3,785
+358% +$112K
DNUT icon
2092
Krispy Kreme
DNUT
$555M
$129K ﹤0.01%
9,453
+4,145
+78% +$57.2K
LZ icon
2093
LegalZoom.com
LZ
$963M
$129K ﹤0.01%
11,759
+10,318
+716% +$136K
RDN icon
2094
Radian Group
RDN
$4.91B
$129K ﹤0.01%
6,544
+5,199
+387% +$109K
STWD icon
2095
Starwood Property Trust
STWD
$6.09B
$129K ﹤0.01%
6,196
-24,310
-80% -$559K
ACVA icon
2096
ACV Auctions
ACVA
$1.24B
$128K ﹤0.01%
+19,640
New +$202K
AMTB icon
2097
Amerant Bancorp
AMTB
$1.13B
$128K ﹤0.01%
4,551
+4,335
+2,007% +$123K
GOGL
2098
DELISTED
Golden Ocean Group
GOGL
$128K ﹤0.01%
11,016
+8,186
+289% +$110K
MZZ icon
2099
ProShares UltraShort MidCap400
MZZ
$2.35M
$128K ﹤0.01%
6,008
+3,356
+127% +$62.7K
STEM icon
2100
Stem
STEM
$50.2M
$128K ﹤0.01%
897
+514
+134% +$85.5K

Similar funds

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.